An interventional study of Virtual Reality Color Trails Test (VR-CTT) and Additional Cognitive or Motor Rehabilitation in Traumatic Brain Injury, sponsored by Dr. Gabriel Zeilig. Not yet recruiting at 1 site in Israel. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by Dr. Gabriel Zeilig · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 35 studies in Brain Injuries, Traumatic with a site in Israel — 9 open to participants now, 10 under way, none of them phase 3. Brain Injuries, Traumatic · Israel.
Among the 35 studies in Brain Injuries, Traumatic with a site in Israel, this one is the 6th largest by planned enrollment of the 19 interventional ones that give a count, is one of 3 that started in 2026, is one of 13 with no phase, and was the 35th registered.
1,724 studies on the registry are indexed under Brain Injuries, Traumatic; 450 are open to participants now.
Browse Brain Injuries, Traumatic studies →9 of the 35 studies in Brain Injuries, Traumatic with a site in Israel are open now. Recruiting first, the newest first:
Sheba Medical Center · Sites in Israel
Ages 18–67 · Healthy volunteers
Motion Informatics LTD · Sites in Israel
Ages 18+
Assaf-Harofeh Medical Center · Sites in Israel
Ages 18+ · Healthy volunteers
Loewenstein Hospital · Sites in Israel
Ages 18–60
Sheba Medical Center · Sites in Israel
Ages 9–18
A study can be open while its sites in Israel have not opened yet or have stopped. Only those recruiting at a site in Israel →
Of the 284 Brain Injuries, Traumatic studies recruiting now, 123 (43%) set no upper age limit and 119 (42%) stop at 75 or younger; 40 take children under 18; 53 take healthy volunteers.
This study: 18 Years to 50 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
35 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 3 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 95 is above the median of 52 across 1,090 interventional studies indexed under Brain Injuries, Traumatic.
Median enrollment 52 across the 19 interventional studies, 68 across the 15 observational. Of the 14 that completed or were terminated, 1 (7%) have results posted.
This tab as a report to print or save as PDF → With an account.
6 of 35 have an industry lead sponsor. The 10 most frequent:
Dr. Gabriel Zeilig is the lead sponsor of 3 studies on the registry; 2 are open to participants now.
Dr. Gabriel Zeilig has 1 study filed under Brain Injuries, Traumatic — fewer than ten, so there is no comparison to draw.
1 of the studies in Brain Injuries, Traumatic with a site in Israel that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07404761Motion Informatics LTDSafety and Effectiveness of Spatial StimelMD (SSMD) in Subjects With Upper Limb Neuromotor Impairments | 2026-12-30 |
Add it to your calendar (.ics) → With an account.
Among the 35 studies in Brain Injuries, Traumatic with a site in Israel, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to evaluate the feasibility, safety, and efficacy of a novel virtual reality (VR)-based cognitive-motor rehabilitation program for individuals with traumatic brain injury (TBI). The intervention uses the Virtual Reality Color Trails Test (VR-CTT), which combines cognitive tasks with upper-limb movements in an immersive virtual environment.
The study consists of two stages. The first stage is a feasibility pilot involving 15 participants who will complete three VR training sessions over one week. The second stage is a randomized controlled trial involving 80 participants allocated to either VR-CTT training combined with standard rehabilitation or a control group receiving standard rehabilitation with additional therapy time. The intervention will consist of nine sessions over three weeks.
The study will assess feasibility, safety, executive functions, upper-limb motor performance, balance, and functional outcomes.
Traumatic brain injury (TBI) frequently results in cognitive and motor impairments that affect everyday functioning. Conventional rehabilitation often addresses these domains separately, although many daily activities require their simultaneous integration. This study evaluates a rehabilitation approach based on the Virtual Reality Color Trails Test (VR-CTT), an immersive system developed at Sheba Medical Center that combines cognitive challenges with coordinated head and upper-limb movements.
The study consists of two sequential stages.
**Stage 1: Feasibility Pilot**
Fifteen participants with TBI will receive three VR-CTT training sessions over one week in addition to standard rehabilitation. Training will progress from seated tasks to more challenging standing activities according to individual abilities. This stage will assess feasibility, safety, usability, and participant satisfaction to inform implementation of the subsequent trial.
**Stage 2: Randomized Controlled Trial**
Eighty participants with TBI will be randomly assigned in a 1:1 ratio to two parallel groups. The intervention group will receive standard rehabilitation supplemented by nine VR-CTT training sessions over three weeks. Training difficulty will increase progressively through changes in cognitive demands, the number of targets, body position, and unilateral or bilateral hand use.
The control group will receive standard rehabilitation supplemented by additional cognitive or motor therapy to match the total treatment time of the intervention group.
Outcome assessments will be conducted before and after the intervention period and will include measures of executive functioning, upper-limb motor performance, balance, everyday functioning, and cognitive-motor interaction. Outcome assessors will remain blinded to group allocation during the randomized stage.
The study aims to determine whether integrated VR-based cognitive-motor training is feasible and safe and whether it improves cognitive and motor outcomes compared with conventional rehabilitation.
**Inclusion Criteria:**
**Exclusion Criteria:**
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Fifteen participants with traumatic brain injury will receive standard rehabilitation supplemented by three VR-CTT training sessions over one week. Sessions will last approximately 45 minutes and progress from seated activities to standing activities according to participants' abilities. This stage will evaluate feasibility, safety, and usability.
Device: Virtual Reality Color Trails Test (VR-CTT)
Forty participants will receive standard inpatient rehabilitation supplemented by nine VR-CTT training sessions over three weeks (three sessions per week, approximately 45 minutes each). Training will progressively increase cognitive and motor demands through changes in target number, task complexity, posture, and hand use.
Device: Virtual Reality Color Trails Test (VR-CTT)
Forty participants will receive standard inpatient rehabilitation supplemented by approximately three hours per week of additional cognitive or motor therapy with a therapist or volunteer, without VR-CTT training. The additional therapy is intended to match the total treatment time of the intervention group.
Behavioral: Additional Cognitive or Motor Rehabilitation
An immersive virtual reality-based cognitive-motor rehabilitation program using the HTC VIVE system and custom-developed VR-CTT software. Participants perform cognitive tasks involving visual search, attention, and cognitive flexibility while reaching toward virtual targets using coordinated upper-limb and head movements. Training difficulty is progressively adjusted by modifying the number of targets, cognitive demands, posture, and hand use. The intervention consists of three sessions over one week in Stage 1 and nine sessions over three weeks in Stage 2.
Additional cognitive or motor rehabilitation exercises administered by a therapist or volunteer, supplementing standard inpatient rehabilitation. Participants receive approximately three hours of additional therapy per week over three weeks to match the total treatment time provided to the VR-CTT intervention group.
Change in Executive Function Composite Score
Change in executive functioning assessed using a composite score derived from the Stroop Test, Rule Shift Cards Test (BADS), and Montreal Cognitive Assessment (MoCA). Standardized scores will be used to evaluate changes in executive control, including inhibition, cognitive shifting, and mental flexibility.
Time frame: Baseline (Week 0) and post-intervention (Week 4).
Change in Upper Limb Motor Function (ARAT)
Change in upper limb motor function assessed using the Action Research Arm Test (ARAT), which evaluates upper extremity motor performance and coordination. Higher scores indicate better motor function.
Time frame: Baseline (Week 0) and post-intervention (Week 4).
Change in Functional Status (FSE)
Change in everyday functional outcomes assessed using the Functional Status Examination (FSE), which evaluates functional limitations following traumatic brain injury.
Time frame: Baseline (Week 0) and post-intervention (Week 4).
Change in Balance (Berg Balance Scale)
Change in static and dynamic balance assessed using the Berg Balance Scale (BBS). Higher scores indicate better balance performance.
Time frame: Baseline (Week 0) and post-intervention (Week 4).
Change in Cognitive-Motor Performance (VR Supermarket Task)
Change in performance on a virtual reality-based supermarket task assessing cognitive-motor integration, including divided attention and sustained attention during simulated everyday activities.
Time frame: Baseline (Week 0) and post-intervention (Week 4).
Change in Dual-Task Performance (Box and Block Test)
Change in dual-task performance assessed using the Dual-Task Box and Block Test (BBT-DT), in which participants transfer blocks while simultaneously performing mental arithmetic.
Time frame: Baseline (Week 0) and post-intervention (Week 4).
Feasibility of VR-CTT Training
Feasibility assessed by adherence to the planned VR-CTT training protocol, including the proportion of scheduled training sessions completed by participants.
Time frame: During the one-week pilot intervention (Stage 1).
Simulator Sickness Symptoms
Simulator sickness symptoms, including nausea, dizziness, headache, and eyestrain, assessed after VR training sessions using the Simulator Sickness Questionnaire (SSQ).
Time frame: After each VR training session during the one-week pilot (Stage 1).
VR-CTT Usability and Participant Satisfaction
Usability and participant satisfaction with the VR-CTT system assessed using post-training feedback questionnaires addressing comfort, ease of use, and overall experience.
Time frame: At completion of the one-week pilot intervention (Stage 1).
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Dec 2026; primary completion for Dec 2029, 36 months later.
Of 444 non-industry interventional studies with no phase under Brain Injuries, Traumatic, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 64. This study's planned 36 months is below that.
Counting every sponsor, half of 466 studies reached it within 41 months; a quarter within 22 and three quarters within 64.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.